A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To determine if long-term treatment with Flibanserin is safe and to monitor the effectiveness
of Flibanserin in Women with HSDD that have already completed a previous study
(511.70/71/.74/.75/.105) with Flibanserin.